On November 28, 2023, ProKidney Corp. notified Deepak Jain, Ph.D., Chief Operating Officer of the Company, of the termination of his employment without cause, effective as of the same date, following which Dr. Jain is expected to continue to serve as a consultant to the Company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.51 USD | -3.04% | -13.44% | +97.19% |
May. 10 | ProKidney Q1 Loss Unchanged From Year Earlier | MT |
May. 10 | ProKidney Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+97.19% | 215M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- PROK Stock
- News ProKidney Corp.
- ProKidney Corp. Announces Termination of Deepak Jain as Chief Operating Officer